Veridical statistics

To access cutting-edge analytics on consensus tools, life science contexts and associated fields, you will need to subscribe to our premium service.


Citations per year

Citations chart

Popular tool citations

chevron_left Variant detection chevron_right
Popular tools chart

Tool usage distribution map

Tool usage distribution map

Associated diseases

Associated diseases

Veridical specifications


Unique identifier OMICS_02630
Name Veridical
Software type Package/Module
Interface Command line interface
Restrictions to use License purchase required
Operating system Unix/Linux, Mac OS
Programming languages C++
License Commercial
Computer skills Advanced
Maintained Yes


Add your version


  • person_outline Veridical Team <>
  • person_outline Peter Rogan <>

Additional information

This tool is integrated into the MutationForecaster software.

Publication for Veridical

Veridical in pipeline

PMCID: 4231324
PMID: 25394353
DOI: 10.1038/srep07063

[…] coverage, resulting from either low expression in the breast tumours carrying the mutation, tissue-specificity of gene expression, or transcript instability from nonsense-mediated decay. although veridical provided experimental validation of predicted splicing mutations, the impact of these and protein coding mutations on tumour progression and biology could not be determined from the present […]

To access a full list of citations, you will need to upgrade to our premium service.

Veridical in publication

PMCID: 4231324
PMID: 25394353
DOI: 10.1038/srep07063

[…] identified arid1a as significantly mutated, concordant with an independent, large-scale, breast cancer genomics study., changes in mrna splicing from the predicted mutations were validated with veridical, which corroborates predicted, aberrant splice isoforms by assessing mutation-derived sequence reads in tumour rna relative to their abundance in controls lacking the mutation. controls […]

To access a full list of publications, you will need to upgrade to our premium service.

Veridical institution(s)
Department of Computer Science, University of Western Ontario, London, ON, Canada; Department of Biochemistry, University of Western Ontario, London, ON, Canada; Cytognomix, Inc., London, ON, Canada
Veridical funding source(s)
Supported by the Canadian Breast Cancer Foundation, Canadian Foundation for Innovation, Canada Research Chairs Secretariat and the Natural Sciences and Engineering Research Council of Canada (NSERC Discovery Grant 371758-2009); by fellowships from the Ontario Graduate Scholarship Program, the Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, the CIHR Strategic Training Program in Cancer Research and Technology Transfer, and the University of Western Ontario.

Veridical reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review Veridical